SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor is drawing attention after 24-month HOPE-3 extension data showed slower upper-limb decline among Duchenne muscular dystrophy patients treated with deramiocel, bolstering interest ahead of the FDAs decision. Many traders view the results as supportive, while others question whether they resolve the FDAs prior statistical concerns; short-squeeze talk is widespread but speculative.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

IBRXs strong, high-volume move has traders focused on a potential breakout, with many speculating that heavy short interest and options activity could amplify the rally. Others caution that there is no confirmed immediate news and the move could fade; bullish sentiment is also supported by expectations for Anktivas international growth and future label expansions or trial updates.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Microns Q4 earnings report and forward guidance are the dominant focus, with traders looking for clues on AI-driven HBM and DRAM demand, pricing, margins, and how long the memory upcycle can last. Many expect a strong report, but others warn that high expectations could trigger a sell-the-news reaction if the outlook disappoints; speculation about a stock split or buyback is also circulating.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovins prolonged selloff and test of 52-week lows have traders focused on bearish analyst concerns that growth is slowing and Unity competition could pressure its ad platform. Bulls counter that AXON e-commerce adoption and other growth indicators are improving, leaving the debate centered on whether the weakness reflects deteriorating fundamentals or an overreaction to analyst commentary.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Fords prolonged slide toward the long-watched $12 level is dominating discussion, with traders split between viewing the shares as oversold and expecting further downside. Community concerns include recurring recalls, supply-chain and production problems, tariffs, and high borrowing costs.

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Liquidia Corp

A Delaware court ruling found that Liquidias Yutrepia infringes United Therapeutics patent, intensifying concern about the drugs commercial prospects and driving a sharp selloff and trading halt. Traders are debating what the ruling means for Yutrepia, with bearish reactions and some buyers arguing the market may be overreacting; a final judgment is still pending.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is drawing attention amid a sharp Treasury selloff and rising long-term yields, as traders debate whether inflation, oil-market pressures, strong growth and federal borrowing concerns will keep rates elevated. Many expect further weakness, while contrarian buyers see an oversold opportunity and look for yields to reverse or policymakers to intervene.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

TRLV is selling off after a federal judge paused the broader cannabis Schedule III rescheduling case while considering whether to reopen the hearing record. Traders debate whether the pause is merely a delay with limited impact on Trulieves medical-focused business, or a setback to the broader rescheduling catalyst.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeings selection to develop the U.S. Navys next-generation F/A-XX fighter is the main catalyst, but traders are debating why the shares reaction has been muted and whether the long-term defense opportunity can outweigh near-term delivery, cash-flow, and execution concerns. The pending SPEEA contract vote is another focus for investors watching for a resolution to labor uncertainty.

Green Thumb Industries, Inc. engages in the manufacture and distribution of branded cannabis products. Its brands include RYTHM, Dogwalkers, Beboe, Good Green, Doctor Solomon’s, and &Shine. It operates through the Retail and Consumer Packaged Goods segments. The Retail segment focuses on retailing cannabis to patients and consumers. The Consumer Packaged Goods segment refers to the cultivation, production, and sale of cannabis products to retail stores. The company was founded by Benjamin Kovler and Max Cohen on February 18, 2002 and is headquartered in Chicago, IL.

Green Thumb Industries Inc - Ordinary Shares (Sub Voting)

Green Thumb Industries

Traders are focused on the pending ALJ recommendation and DEA decision on broader cannabis rescheduling, which they speculate could ease tax burdens and pave the way for exchange uplisting and institutional investment. Many cite Green Thumbs financial strength and buybacks as reasons for optimism, while others are frustrated by delays, MSOS-related selling pressure, and the stocks lag versus cannabis peers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

IJH, TWLO, OKTA, FTI: ETF Outflow Alert

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core S&P Mid-Cap ETF (Symbol: IJH) where we have detected an approximate $967.1 million dollar outflow -- that's a 0.8% decrease week ov...

Should iShares Core S&P Mid-Cap ETF (IJH) Be on Your Investing Radar?

GME Pops 3% After the Bell As CEO Buys $26M Worth of Shares   

Equity

According to a filing with the Securities and Exchange Commission on Monday, Cohen bought 1.15 million GME shares in multiple transactions priced between $22.76 and $23.02 for roughly $26.4 million.


Not A ‘Gangbusters Launch’ — Arrowhead Predicts Slow Burn to $3B-$4B Peak For Redemplo, Highlights ‘Massive Pipeline’ 

Redemplo is already approved by the U.S. Food and Drug Administration (FDA) to lower very high triglycerides in the rare condition familial chylomicronemia syndrome.


CELH Ticks Up After-Hours As Director DeSantis Follows CEO With $1M Buy

DeSantis, an independent director and son of late Celsius backer Carl DeSantis, purchased 20,000 shares on Monday at a weighted average of $27.65 and another 16,000 on Tuesday at $27.95.


ARWR Stock Heads For Worst Day In Over A Year Despite Positive Cholesterol Drug Data — Is This A ‘Sell The News’ Move?

ARWR had already run hard into the catalyst and remains far above last year’s levels after a 52-week high near $95 in July. 


EXEL Stock Slides After FDA Adds Three Months To Cancer Drug Review — William Blair Sees More Swings In Near Term

The FDA told Exelixis on Thursday that it had extended the review of a new drug application for zanzalintinib plus Roche’s Tecentriq in patients whose colorectal cancer has spread. 

CELH Stock Edges Up After-Hours On CEO Share Purchase, But Not Enough To Win Retail Investors’ Confidence

According to a filing with the Securities and Exchange Commission, John Fieldly purchased 18,000 shares on September 10 at a weighted average price of $27.4357. 


GME Stock Jumps 4% After-Hours — What’s Driving The Rally?

According to a filing with the Securities and Exchange Commission, CEO Ryan Cohen bought a million shares of GameStop. 


AVAV Stock Rebounds After-Hours On Record Sales And $1.5B Backlog — CEO Says FY27 ‘Off To A Strong Start’ 

Chief Executive Wahid Nawabi said fiscal 2027 “is off to a strong start, with record first-quarter revenue and funded backlog and landmark strategic wins.”


iShares Trust - iShares Core S&P Mid-Cap ETF

Neutral Sentiment

Double beat (rev + EPS)

Revenue beat, EPS miss

EPS beat, revenue miss

Double miss

Micron ($MU) reports earnings after the close today. What do you expect?

Stocktwits

) reports earnings after the close today. What do you expect?

IJH iShares Core S&P Mid-Cap ETF